The topical antiseptic agent triclocarban (TCC) is a common additive in many antimicrobial household consumables, including soaps and other personal care products. Long-term usage of the mass-produced compound and a lack of understanding of its fate during sewage treatment motivated the present mass balance analysis conducted at a typical U.S. activated sludge wastewater treatment plant featuring a design capacity of 680 million liters per day. Using automated samplers and grab sampling, the mass of TCC contained in influent, effluent and digested sludge was monitored by isotope dilution liquid chromatography (tandem) mass spectrometry. The average mass of TCC (mean ± standard deviation) entering and exiting the plant in influent (6.1 ± 2.0 μg/L) and effluent (0.17 ± 0.03 μg/L) was 3,737 ± 694 and 127 ± 6 g/d, respectively, indicating an aqueous-phase removal efficiency of 97 ± 1%. Tertiary treatment by chlorination and sand filtration provided no detectable benefit to the overall removal. Due to strong sorption of TCC to wastewater particulate matter (78 ± 11% sorbed), the majority of the TCC mass was sequestered into sludge in the primary and secondary clarifiers of the plant. Anaerobic digestion for 19 days did not promote TCC transformation, resulting in an accumulation of the antiseptic compound in dewatered, digested municipal sludge to levels of 51 ± 15 mg/kg dry weight (2,815 ± 917 g/d). In addition to the biocide mass passing through the plant contained in the effluent (3 ± 1%), 76 ± 30% of the TCC input entering the plant underwent no net transformation and instead partitioned into and accumulated in municipal sludge. Based on the rate of beneficial reuse of sludge produced by this facility (95%), which exceeds the national average (63%), study results suggest that approximately three quarters of the mass of TCC disposed of by consumers in the catchment area of the plant ultimately is released into the environment by application of municipal sludge (biosolids) on land used in part for agriculture.